<DOC>
	<DOCNO>NCT02374086</DOCNO>
	<brief_summary>Angina absence obstructive coronary artery disease highly prevalent woman , lead increase risk major cardiovascular event , include myocardial infarction , stroke , heart failure . Annual mortality rate ten-fold high mortality breast cancer , lifetime cost health care woman non-obstructive chest pain close $ 1 million . Coronary microvascular dysfunction major etiological feature disease , may contribute disease progression . Despite general understanding , effective treatment remain elusive . This pilot study test whether regular exercise training improve/reverse coronary microvascular dysfunction woman angina obstructive coronary artery disease .</brief_summary>
	<brief_title>Benefits Exercise Training Women With Ischemic Syndrome</brief_title>
	<detailed_description>We study 10 woman sign symptom ischemia evidence obstructive coronary artery disease . Procedures : Aerobic fitness : Incremental exercise test volitional exhaustion exercise bike ass maximal rate oxygen consumption . Cardiac magnetic resonance imaging : To assess cardiac morphology function . Cardiac perfusion imaging : Using MRI , ass rate uptake contrast medium ( gadolinium ) rest response vasodilating substance ( adenosine ) evaluate myocardial perfusion reserve . Protocol : Participants undergo aerobic fitness testing , cardiac MRI perfusion image baseline follow 8-weeks regular exercise training .</detailed_description>
	<criteria>1 . Women persistent chest pain obstructive disease ( defined 50 % luminal diameter stenosis &gt; 1 epicardial coronary artery ) 2 . Fully understand willing undergo study procedure 3 . Understanding willing sign consent form . 1 . Acute coronary syndrome ( define WHO ) , cardiogenic shock require inotropic intraaortic balloon support ; 2 . Planned percutaneous coronary intervention coronary artery bypass graft establish obstructive CAD ischemia eligible revascularization , 3 . Acute myocardial infarction ; 4 . Patients concurrent cardiogenic shock require inotropic intraaortic balloon support ; 5 . Prior noncardiac illness estimate life expectancy &lt; 4 year ; 6 . Unable give inform consent ; 7 . Allergy contraindication cardiac magnetic resonance imaging , include renal failure , claustrophobia , asthma , uncontrolled moderate hypertension ( sit blood pressure &gt; 160/95 mmHg measurement record least 2 occasion ) , condition likely influence outcome : Severe lung , creatinine &gt; 1.8 CrCl â‰¤ 50ml/min ) hepatic disease ; 8 . Contraindications adenosine regadensoson ( Lexiscan ) 9 . Surgically uncorrected significant congenital valvular heart disease disease likely fatal require frequent hospitalization within next six month ; 10 . Adherence retention issue ; 11 . Unwilling complete followup evaluation ; 12 . Aortic stenosis ( valve area &lt; 1.5cm ) ; 13 . Left ventricular systolic dysfunction ( ejection fraction &lt; 35 % ) ; 14 . Taking potent CYP3A4 inhibitor ( ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) ; 15 . Women pregnant . 16 . Allergy animal dander . 17 . Unable perform exercise</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>